Ohad is a Partner at Pontifax, where he is focused on scouting and project evaluation. He also serves on the board of several of Pontifax’s portfolio companies including AgomAb, Precirix, Step Pharma, Pi Therapeutics and Kamari Pharma. Ohad obtained his MSc in Biology from Tel-Aviv University.
By continuing to use the site, you agree to the use of cookies. Privacy Policy
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
